Clinical Trials Logo

Influenza Vaccination in Seniors clinical trials

View clinical trials related to Influenza Vaccination in Seniors.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01737580 Completed - Clinical trials for Influenza Vaccination in Seniors

Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

Start date: April 2013
Phase: Phase 1
Study type: Interventional

The application of the TLR7/8 (Toll Like Receptor) agonist gel (immune response helper) resiquimod will enhance the immune response to the intradermal influenza vaccine in seniors 65-75 years of age.